Skip to main content
. Author manuscript; available in PMC: 2016 Nov 28.
Published in final edited form as: AIDS. 2015 Jul;29(Suppl 2):S129–S136. doi: 10.1097/QAD.0000000000000713

Table 2.

Sample Priority Indicators and ICAP minimum targets.

95% of patients in HIV care and treatment receive cotrimoxazole
  (CTX) prophylaxis
90% of patients still alive and on treatment 12 months after initiating
  ART
95% of patients in HIV care and treatment screened for TB at their last
  clinical visit
95% of HIV positive pregnant women receive multidrug antiretrovirals
  (including ART) in ANC to reduce MTCT

ANC, antenatal case; ART, antiretroviral therapy; MTCT, mother-to-child transmission; TB, tuberculosis.